Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes

Neuropharmacology

Volumn 40, Issue 7, 2001, Pages 937-946

  Mazario, Javier ^a   Gaitan, Gema ^a   Herrero, Juan F ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Inflammation; Non steroidal antiinflammatory drugs; Pain; Single motor unit; Wind up

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DEXKETOPROFEN; FLURBIPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; SC 58560; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SELECTIVITY; ENZYME INHIBITION; KNEE ARTHRITIS; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SPINAL REFLEX; WITHDRAWAL REFLEX;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HYPERALGESIA; ISOENZYMES; LACTONES; MALE; MEMBRANE PROTEINS; MICE; ORGANIC CHEMICALS; PAIN MEASUREMENT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, WISTAR; SULFONAMIDES; SULFONES;

EID: 0034992873     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(01)00020-X     Document Type: Article

References (44)

1. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus
2. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation
3. Pure enantiomers of 2-arylpropionic acids: Tools in pain research and improved drugs in rheumatology
4. Rofecoxib, a specific inhibitor of cyclooxygenase-2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip
5. Rofecoxib [Vioxx MK-0966 4-(4′-Methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles
6. Altered nociception, analgesia and aggression in mice lacking the substance P receptor
7. Renal abnormalities and an altered response in mice lacking cyclooxygenase II
8. The intraspinal release of prostaglandin E2 in a model of acute arthritis is accompanied by an up-regulation of cyclo-oxygenase-2 in the spinal cord
9. Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation
10. COX-2 inhibitors
11. Changes in nociceptive reflex facilitation during carrageenan-induced arthritis
12. The effects of sham and full spinalization on the systemic potency of μ- and k-opioids on spinal nociceptive reflexes in rats
13. Reversal by naloxone of the spinal antinociceptive actions of a systemically-administered NSAID
14. Wind-up of spinal cord neurones and pain sensation: Much ado about something?
15. Central and peripheral actions of the NSAID ketoprofen on spinal cord nociceptive reflexes
16. Human cyclooxygenase-2 cDNA
17. Tonic versus phasic pain: Dose-related effects of ketoprofen
18. Rheumatoid arthritis. New disease-modifying and anti-inflammatory drugs
19. COX-2 inhibitors and dental pain control
20. Analgesic activity of the novel COX-2 preferring NSAID meloxicam in mono-arthritic rats: Central and peripheral components
21. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
22. Cyclooxigenase-2 specificity and its clinical implications
23. Hyperalgesia mediate by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition
24. Preclinical and clinical development of dexketoprofen
25. Antinociceptive effects of metamizol (dipyrone) in rat single motor units
26. The NSAID dexketoprofen trometamol is as potent as μ-opioids in the depression of wind-up and spinal cord nociceptive reflexes in normal rats
27. Analgesia induced by nonsteroidal 31. Rofecoxib phase III protocol 035 study groupantiinflammatory drugs in monoarthritic rats is due to the inhibition of both cyclooxygenase isoenzymes
28. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
29. Diffusion of intramuscular ketoprofen into the cerebrospinal fluid
30. Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages
31. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats
32. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxigenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-y]benzenesulfonamide (SC-58635, celecoxib)
33. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor
34. The effects of S- and R-flurbiprofen on the inflammation-evoked intraspinal release of immunoreactive substance P - A study with antibody microprobes
35. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
36. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
37. Pharmacological analysis of cyclooxygenase-1 in inflammation
38. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
39. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity
40. Selective COX-2 inhibitors: Is the water becoming muddy?
41. Distribution and expression of cyclooxygenase (COX) isoenzymes their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs)
42. Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability
43. COX-1 COX-2 and COX-3 and the future treatment of chronic inflammatory disease